Although there was no significant difference between the Bailing group and the control group in anti-ds-DNAIgM levels and complement C3 levels (which is associated with the existence of some immune diseases like SLE), other indicators of the disease, such as SLEDAI score, Alb, 24 h urinary protein, serum creatinine, and the number of effective treatments and complications, improved. This evidence concerns the gene C3 and systemic lupus erythematosus.